Download PDF
CC BY-NC-ND 4.0 · Ann Natl Acad Med Sci 2022; 58(01): 017-021
DOI: 10.1055/s-0041-1741063
Original Article

Prevalence of Latent Autoimmune Diabetes in Adult Based on the Presence of GAD 65 Antibodies in North-Eastern Uttar Pradesh, India

Himalina Sangma
1   Department of Pathology, Motilal Nehru Medical College, Prayagraj, Uttar Pradesh, India
,
Anshul Singh
1   Department of Pathology, Motilal Nehru Medical College, Prayagraj, Uttar Pradesh, India
,
Anubha Srivastava
2   Department of Medicine, Motilal Nehru Medical College, Prayagraj, Uttar Pradesh, India
,
Vatsala Misra
1   Department of Pathology, Motilal Nehru Medical College, Prayagraj, Uttar Pradesh, India
› Author Affiliations Funding None.
› Further Information
   Permissions and Reprints

Abstract

Objective The objective of this paper was (1) to study the prevalence of latent autoimmune diabetes in adult (LADA) in the region of north-eastern Uttar Pradesh, India, based on the positivity for glutamic acid decarboxylase 65 (GAD65) antibodies and (2) to compare the glycemic profile between GAD65-positive and GAD65-negative subjects.

Materials and Methods The subjects were of more than 30 years of age, with either recently diagnosed pre-diabetes/diabetes presenting with the hemoglobin A1c (HbA1c) level of ≥5.7% or already diagnosed cases of type 2 diabetes mellitus (T2DM) who had no requirement of insulin therapy for at least 6 months from the time of their diagnosis. All the patients were natives of north-eastern Uttar Pradesh. The GAD65 test was done by the enzyme-linked immunosorbent assay. Further, the glycemic status of GAD-positive and GAD-negative subjects were compared on the basis of fasting blood sugar (FBS), fasting insulin (FI), and homeostatic model assessment for insulin resistance (HOMA-IR). The “unpaired t-test” was used to compare and assess the significance of differences between the glycemic profile of GAD65-positive and GAD65-negative subjects using the GraphPad Prism Scientific Software, San Diego, CA, United States. The p-value of <0.05 was considered to be significant.

Results A total of 77 patients were included in the study, with the age group ranging from 30 to 75 years (47.81 ± 12.9 years) with the male–female ratio of 1:2.6. The prevalence of LADA was found to be 51.95%. On comparing GAD65-positive and GAD65-negative groups, a higher value of HbA1c levels and FBS were found in the former, whereas FI and HOMA-IR were found to be higher in the latter. On testing for significance of difference, only FI and HbA1c values were significant (p-value <0.0001).

Conclusion LADA can no longer be considered a rare type of diabetes mellitus, with the present study showing a high prevalence of LADA in this north eastern region of Uttar Pradesh. Identification of adult-onset diabetics accurately as LADA or true T2DM is very crucial for the appropriate treatment, as LADA patients require insulin inevitably and much earlier than true T2DM patients, who can be managed mostly on oral hypoglycemic agents with seldom requirement of insulin.

Keywords

type 1.5 diabetes - slowly evolving immune-mediated diabetes of adult - double diabetes - GAD65 antibody - insulin


Publication History

Article published online:
10 January 2022

© 2022. National Academy of Medical Sciences (India). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, Mackay IR. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 1993; 42 (02) 359-362
    CrossrefPubMedGoogle Scholar
  • 2 World Health Organization. Classification of diabetes mellitus. Accessed December 8, 2021 at: https://apps.who.int/iris/handle/10665/325182
    Google Scholar
  • 3 Saboo B. Latent Autoimmune Diabetes in Adults. Available at: http://apiindia.org/wp-content/uploads/medicine_update_2013/chap39.pdf
    Google Scholar
  • 4 Carlsson S. Etiology and pathogenesis of latent autoimmune diabetes in adults (LADA) compared to type 2 diabetes. Front Physiol 2019; 10: 320
    CrossrefPubMedGoogle Scholar
  • 5 Kumar A, de Leiva A. Latent autoimmune diabetes in adults (LADA) in Asian and European populations. Diabetes Metab Res Rev 2017; 33 (05) DOI: 10.1002/dmrr.2890.
    CrossrefPubMedGoogle Scholar
  • 6 Joshi SR, Parikh RM. India–diabetes capital of the world: now heading towards hypertension. J Assoc Physicians India 2007; 55: 323-324
    PubMedGoogle Scholar
  • 7 Hawa MI, Kolb H, Schloot N. et al; Action LADA consortium. Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7. Diabetes Care 2013; 36 (04) 908-913
    CrossrefPubMedGoogle Scholar
  • 8 Pieralice S, Pozzilli P. Latent autoimmune diabetes in adults: a review on clinical implications and management. Diabetes Metab J 2018; 42 (06) 451-464
    CrossrefPubMedGoogle Scholar
  • 9 American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care 2015; 38 (Suppl): S8-S16
    CrossrefPubMedGoogle Scholar
  • 10 Action LADA. Accessed September 8, 2015 at: http://www.actionlada.org/why/why.html
  • 11 Takagi S, Miura J, Hoshina S, Uchigata Y, Babzono T. Association of anti-GAD antibody positivity measured by RIA and ELISA with clinical characteristics in patients with type 1 diabetes. Diabetes 2018; 67 (01) DOI: 10.2337/db18-1700-P.
    CrossrefGoogle Scholar
  • 12 Sachan A, Zaidi G, Sahu RP, Agrawal S, Colman PG, Bhatia E. Low prevalence of latent autoimmune diabetes in adults in northern India. Diabet Med 2015; 32 (06) 810-813
    CrossrefPubMedGoogle Scholar
  • 13 Brahmkshatriya PP, Mehta AA, Saboo BD, Goyal RK. Characteristics and prevalence of latent autoimmune diabetes in adults (LADA). ISRN Pharmacol 2012; 2012: 580202
    CrossrefPubMedGoogle Scholar
  • 14 Unnikrishnan AG, Singh SK, Sanjeevi CB. Prevalence of GAD65 antibodies in lean subjects with type 2 diabetes. Ann N Y Acad Sci 2004; 1037 (01) 118-121
    CrossrefPubMedGoogle Scholar
  • 15 Guntaka M, Jangir AK, Hanmayyagari B. et al. Prevalence of latent autoimmune diabetes in adults: experience from a single centre in south India. Paripex Indian J Res 2019; 8 (03) 148-150
    Google Scholar
  • 16 Melmed S, Polonsky KS, Larsen PR, Kronenberg HM. Williams Textbook of Endocrinology. 13th ed.. Philadelphia, PA: Elsevier Saunders; 2016
    Google Scholar
  • 17 Lee CH, Shih AZL, Woo YC. et al. Optimal cut-offs of homeostasis model assessment of insulin resistance (HOMA-IR) to identify dysglycemia and type 2 diabetes mellitus: a 15-year prospective study in Chinese. PLoS One 2016; 11 (09) e0163424
    CrossrefPubMedGoogle Scholar
  • 18 Carlsson A, Sundkvist G, Groop L, Tuomi T. Insulin and glucagon secretion in patients with slowly progressing autoimmune diabetes (LADA). J Clin Endocrinol Metab 2000; 85 (01) 76-80
    PubMedGoogle Scholar
  • 19 Mishra R, Chesi A, Cousminer DL. et al; Bone Mineral Density in Childhood Study. Relative contribution of type 1 and type 2 diabetes loci to the genetic etiology of adult-onset, non-insulin-requiring autoimmune diabetes. BMC Med 2017; 15 (01) 88
    CrossrefPubMedGoogle Scholar
  • 20 Andersen MK, Hansen T. Genetic aspects of latent autoimmune diabetes in adults: a mini-review. Curr Diabetes Rev 2019; 15 (03) 194-198
    CrossrefPubMedGoogle Scholar
  • 21 Andersen MK, Sterner M, Forsén T. et al. Type 2 diabetes susceptibility gene variants predispose to adult-onset autoimmune diabetes. Diabetologia 2014; 57 (09) 1859-1868
    CrossrefPubMedGoogle Scholar
  • 22 Cervin C, Lyssenko V, Bakhtadze E. et al. Genetic similarities between latent autoimmune diabetes in adults, type 1 diabetes, and type 2 diabetes. Diabetes 2008; 57 (05) 1433-1437
    CrossrefPubMedGoogle Scholar
  • 23 Akbar DH, Ahmed MM, Al-Mughales J. Thyroid dysfunction and thyroid autoimmunity in Saudi type 2 diabetics. Acta Diabetol 2006; 43 (01) 14-18
    CrossrefPubMedGoogle Scholar
  • 24 Mohammadi M, Khazaei HA. Characteristics and prevalence of latent autoimmune diabetes in adults (LADA) in Torbat-e Heydarieh, Iran. IJML 2018; 5 (04) 255-263
    Google Scholar
  • 25 Hossein GM, Maryam S, Saeed E, Hamid N, Mahdieh M. The prevalence of latent autoimmune diabetes in adults and its correlates in patients with type 2 diabetes in Kerman, Iran [2011]. Diabetes Metab Syndr 2015; 9 (02) 104-107
    CrossrefPubMedGoogle Scholar
  • 26 Kucera P, Nováková D, Behanová M, Novak J, Tlaskalová-Hogenová H, Andel M. Gliadin, endomysial and thyroid antibodies in patients with latent autoimmune diabetes of adults (LADA). Clin Exp Immunol 2003; 133 (01) 139-143
    CrossrefPubMedGoogle Scholar
  • 27 Kawasaki E, Okada A, Uchida A. et al. Discrepancy of glutamic acid decarboxylase 65 autoantibody results between RSR radioimmunoassay and enzyme-linked immunosorbent assay in patients with type 1 diabetes is related to autoantibody affinity. J Diabetes Investig 2019; 10 (04) 990-996
    CrossrefPubMedGoogle Scholar
  • 28 Buzzetti R, Di Pietro S, Giaccari A. et al; Non-Insulin Requiring Autoimmune Diabetes Study Group. High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes. Diabetes Care 2007; 30 (04) 932-938
    CrossrefPubMedGoogle Scholar
  • 29 Brophy S, Yderstraede K, Mauricio D. et al; Action LADA Group. Time to insulin initiation cannot be used in defining latent autoimmune diabetes in adults. Diabetes Care 2008; 31 (03) 439-441
    CrossrefPubMedGoogle Scholar
  • 30 Zaharieva ET, Velikova TV, Tsakova AD, Kamenov ZA. Prevalence of positive diabetes associated autoantibodies among type 2 diabetes and related metabolic and inflammatory differences in a sample of the Bulgarian population. J Diab Res 2017. Available at: https://doi.org/10.1155/2017/9016148
    CrossrefPubMedGoogle Scholar
  • 31 Desai M, Zeggini E, Horton VA. et al. An association analysis of the HLA gene region in latent autoimmune diabetes in adults. Diabetologia 2007; 50 (01) 68-73
    CrossrefPubMedGoogle Scholar
  • 32 Hawa MI, Fava D, Medici F. et al. Antibodies to IA-2 and GAD65 in type 1 and type 2 diabetes: isotype restriction and polyclonality. Diabetes Care 2000; 23 (02) 228-233
    CrossrefPubMedGoogle Scholar